Safety of Fresh Produce; Public Hearings; Request for Comments, 8750-8756 [07-891]
Download as PDF
8750
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued
21 CFR Section
FDA Form Number
No. of
Respondents
Annual Frequency
per Response
Total Annual
Responses
Hours per
Response
Total Hours
1040.11(a)(2)
190
1.00
190
10
1,900
1040.20(d)(1)(ii) through
(d)(1)(vi) and (e)(1) and (e)(2)
110
1.00
110
10
1,100
1040.30(c)(1)(ii)
1
1.00
1
1
1
1040.30(c)(2)
7
1.00
7
1
7
10
1.00
10
56
560
1050.10(d)(1) through (d)(4) and
(f)(1) through (f)(2)(iii)
Total
1There
107,209
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
21 CFR Section
No. of
Recordkeepers
Annual Frequency
per Recordkeeping
Total Annual
Records
Hours per
Record
Total Hours
1002.30 and 1002.31(a)
1,150
1,655.5
1,903,825
198.7
228,505
1002.40 and 1002.41
2,950
49.2
145,140
2.4
7,080
1020.30(g)
22
1
22
0.5
11
1040.10(a)(3)(ii)
83
1
83
1.0
83
Totals
cprice-sewell on PROD1PC62 with NOTICES
1There
235,679
are no capital costs or operating and maintenance costs associated with this collection of information.
The information collection
requirements under OMB control
number 0910–0564 and Form FDA
3626, the data collection instrument for
this collection, have been consolidated
under the information collection
activity of OMB control number 0910–
0025, thus resulting in an adjustment
(increase) in the current burden
estimate.
The burden estimates were derived by
consultation with FDA and industry
personnel and actual data collected
from industry. An evaluation of the type
and scope of information requested was
also used to derive some time estimates.
For example, disclosure information
primarily requires time only to update
and maintain existing manuals. Initial
development of manuals has been
performed except for new firms entering
the industry. When information is
generally provided to users, assemblers,
or dealers in the same manual, they
have been grouped together in the
‘‘Estimated Annual Reporting Burden’’
table (table 1 of this document).
The following information collection
requirements are not subject to review
by OMB because they do not constitute
a ‘‘collection of information’’ under the
PRA: Sections 1002.31(c); 1003.10(a),
(b), and (c); 1003.11(a)(3) and (b);
1003.20(a) through (h); 1003.21(a)
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
through (d); 1003.22(a) and (b);
1003.30(a) and (b); 1003.31(a) and (b);
1004.2(a) through (i); 1004.3(a) through
(i); 1004.4(a) through (h); 1005.21(a)
through (c); and 1005.22(b). These
requirements ‘‘apply to the collection of
information during the conduct of
general investigations or audits’’ (5 CFR
1320.4(b)). The following labeling
requirements are also not subject to
review under the PRA because they are
a public disclosure of information
originally supplied by the Federal
Government to the recipient for the
purpose of disclosure to the public
(1410.10 of the FDA Staff Manual Guide
and §§ 1020.10(c)(4), 1030.10(c)(6),
1040.10(g), 1040.30(c)(1), and
1050.10(d)(1)).
Dated: February 20, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–3258 Filed 2–26–07; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N–0051]
Safety of Fresh Produce; Public
Hearings; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public hearings;
request for comments.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is announcing
two public hearings concerning the
safety of fresh produce. The purpose of
the hearings is for FDA to share
information about recent outbreaks of
foodborne illness associated with
microbial contamination of fresh
produce, and to solicit comments, data,
and other scientific information about
current agricultural and manufacturing
practices used to produce, harvest, pack,
cool, process, and transport fresh
produce; risk factors for contamination
of fresh produce associated with these
practices; and possible measures by
FDA to enhance the safety of fresh
produce.
The first public hearing will be
held on March 20, 2007, from 9 a.m. to
DATES:
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\27FEN1.SGM
27FEN1
cprice-sewell on PROD1PC62 with NOTICES
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
5 p.m. The second public hearing will
be held on April 13, 2007, from 9 a.m.
to 5 p.m. See section V of this document
for additional dates on how to
participate in the hearings. Submit
written or electronic comments (i.e.,
submissions other than notices of
participation and the text,
comprehensive outline, or summary of
an oral presentation) by June 13, 2007.
ADDRESSES: The first public hearing will
be held at the Ronald V. Dellums
Federal Building, Edward Roybal
Auditorium, 1301 Clay St., 3d floor,
Oakland, CA 94612. The second public
hearing will be held at the Harvey W.
Wiley Federal Building, Food and Drug
Administration, Center for Food Safety
and Applied Nutrition, 5100 Paint
Branch Pkwy., College Park, MD,
20740–3835 (Metro stop: College Park
on the Green Line).
Submit electronic notices of
participation for either hearing to https://
www.cfsan.fda.gov/~comm/
register.html. We encourage you to use
this method of registration, if possible.
You may also submit oral or written
notices of participation by phone, by
fax, or by e-mail, or submit the written
full text, comprehensive outline, or
summary of any oral presentation by fax
or by e-mail to Isabelle Howes, U.S.
Department of Agriculture Graduate
School, 202–314–4713, FAX: 202–479–
6801, or e-mail:
Isabelle_Howes@grad.usda.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Submit electronic comments
to https://www.fda.gov/dockets/
ecomments.
Instructions: All submissions and
comments received must include the
agency name and docket number found
in brackets in the heading of this
document. All submissions and
comments received may be posted
without change to https://www.fda.gov/
ohrms/dockets/default.htm, including
any personal information provided. For
additional information on submitting
comments, see section VI in the
SUPPLEMENTARY INFORMATION section of
this document.
Transcripts of the hearings will be
available for review at the Division of
Dockets Management and on the
Internet at https://www.fda.gov/ohrms/
dockets/default.htm approximately 30
days after the hearing.
FOR FURTHER INFORMATION CONTACT:
To submit an oral or written notice of
participation by phone, by fax, or
by e-mail, or the written full text,
comprehensive outline, or summary
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
of any oral presentation by fax or by
e-mail: Isabelle Howes, U.S.
Department of Agriculture Graduate
School, 202–314–4713, FAX: 202–
479–6801, or e-mail:
Isabelle_Howes@grad.usda.gov. All
participants must complete
registration. Following registration,
you will receive a confirmation
notice which also includes hotel
and parking information.
For all other questions about the
hearings or if you need special
accommodations due to a
disability: Juanita Yates, Center for
Food Safety and Applied Nutrition,
Food and Drug Administration,
301–436–1731, e-mail:
Juanita.Yates@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
A. Food Safety and Fresh Produce
FDA is responsible for ensuring the
safety of all domestic and imported
fresh and fresh-cut fruits and vegetables
consumed in the United States. Fresh
fruits and vegetables are those that are
likely to be sold to consumers in an
unprocessed or minimally processed
(i.e., raw) form. Fresh fruits and
vegetables may be intact and whole,
such as whole apples, or cut in the act
of harvest, such as heads of lettuce and
bunches of broccoli. As used in this
document, the term ‘‘fresh-cut produce’’
refers to minimally processed fruits and
vegetables that have been altered in
form by peeling, slicing, chopping,
shredding, coring, or trimming, with or
without washing or other treatment,
prior to being packaged for use by the
consumer or retail establishment.
Examples of fresh-cut products are
shredded lettuce, sliced tomatoes, salad
mixes, peeled baby carrots, broccoli
florets, and cut melons. Fresh-cut
produce does not require additional
preparation, processing, or cooking
before consumption, with the possible
exception of washing or the addition of
salad dressing or seasoning. In this
document, we use the term ‘‘fresh
produce’’ to describe all fresh and freshcut fruits and vegetables consumed in
the United States.
Because most fresh produce is grown
in a natural environment, it is
vulnerable to contamination with
pathogens (i.e., bacteria or other
organisms that can cause disease).
Factors that may affect the occurrence of
such contamination include agricultural
and/or processing water quality, the use
of manure as fertilizer, the presence of
wild or domestic animals in or near
fields or packing areas, worker health
and hygiene, environmental conditions,
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
8751
production activities, and equipment
and facility sanitation. Consequently,
the manner in which fresh produce is
grown, harvested, packed, processed,
transported, distributed, and prepared is
crucial to minimizing the risk of
microbial contamination. (We use the
term ‘‘microbial contamination’’ to refer
to contamination with any
microorganism.)
Data reported to the U.S. Centers for
Disease Control and Prevention (CDC)
indicate that between 1973 and 1997
reported outbreaks of foodborne illness
in the United States associated with
fresh produce increased in absolute
numbers and as a proportion of all
reported foodborne outbreaks (Ref. 1).
(By ‘‘outbreak,’’ we mean the occurrence
of two or more cases of a similar illness
resulting from the ingestion of a
common food.) Unpublished data
compiled by FDA indicate that from
1996 to 2006 there were approximately
72 reported outbreaks of foodborne
illness associated with approximately
20 fresh produce commodities. Of this
total, 12 outbreaks were associated with
tomatoes, 11 outbreaks were associated
with melons, and 24 outbreaks were
associated with leafy greens such as
lettuce and spinach (Ref. 2). These
outbreaks involved a number of
pathogens, including Escherichia coli
(E. coli) O157:H7 and Salmonella
species, and both domestic and
imported produce. These totals include
only those outbreaks in which our
investigation has indicated that the
contamination of the produce was not a
result of exposure to an infected food
handler or other unsafe food handling
practice at the place of preparation and
consumption (i.e., home or restaurant).
When there is an outbreak of
foodborne illness, we work with
Federal, State, and local agencies to
identify the source of the outbreak and
minimize the public health impact. For
example, on September 14, 2006, we
issued a news release alerting
consumers about an outbreak of E. coli
O157:H7 in multiple States and advising
the public not to eat bagged fresh
spinach because it had been implicated
in the outbreak (Ref. 3). We continued
to issue updated press releases for
approximately four weeks. During the
course of the outbreak, approximately
200 illnesses were reported to the CDC,
including more than 30 cases of
hemolytic uremic syndrome (HUS, a
condition occurring mainly in children
that can result in kidney failure), more
than 100 hospitalizations, and 3 deaths
(Ref. 4). In addition to working to
identify the food involved in the
outbreak, we worked with others to
trace the source of the implicated
E:\FR\FM\27FEN1.SGM
27FEN1
8752
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
cprice-sewell on PROD1PC62 with NOTICES
product to packing, cooling and
processing facilities involved and to the
farm to identify practices or conditions
that may have contributed to the
contamination of the produce.
One challenge faced by public health
officials during an outbreak is to quickly
identify through traceback the sources
of contamination. FDA’s regulations
require the establishment and
maintenance of records by persons who
manufacture, process, pack, transport,
distribute, receive, hold, or import food
in the United States (21 CFR 1.326–
1.368). Such records allow for the
identification of the immediate previous
sources and immediate subsequent
recipients of food, and thereby help
FDA and other authorities determine the
source and cause of the event. Farms
and restaurants are excluded from these
requirements. Traceback can be
particularly problematic when fresh
produce is involved.
Eating fruits and vegetables is an
important part of a healthy diet (Ref. 5).
We place a high priority on identifying
and implementing measures that can
reduce the incidence of foodborne
illness associated with fresh produce.
B. Guidance Documents and Letters
Issued by FDA to Enhance the Safety of
Fresh Produce
In 1998, FDA issued guidance to
industry entitled ‘‘Guide to Minimize
Microbial Food Safety Hazards for Fresh
Fruits and Vegetables’’ (GAPs/GMPs
Guide) (Ref. 6). This guide recommends
good agricultural practices (GAPs) and
good manufacturing practices (GMPs)
that growers, packers, and shippers can
undertake to address common risk
factors in their operations and thereby
minimize food safety hazards
potentially associated with fresh
produce. Implementation of risk
reduction measures is critical; as the
GAPs/GMPs Guide notes, current
technologies cannot eliminate all
potential food safety hazards associated
with fresh produce that will be eaten
raw.
On February 5, 2004, FDA issued a
letter to firms that grow, pack, or ship
fresh lettuce and fresh tomatoes,
expressing concern regarding outbreaks
of foodborne illness associated with the
consumption of fresh lettuce and fresh
tomatoes, and recommending actions to
enhance the safety of these products
(Ref. 7). On November 4, 2005, FDA
issued a second letter to firms that grow,
pack, process or ship fresh and fresh-cut
lettuce, reiterating concerns about
continuing outbreaks (Ref. 8). In the
November 2005 letter, FDA strongly
encouraged applicable firms to review
their current operations in light of the
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
GAPs\GMPs Guide, as well as other
available information regarding the
reduction or elimination of pathogens
on fresh produce. FDA encouraged firms
to consider modifying their operations
to ensure that they were taking the
appropriate measures to provide a safe
product to the consumer. FDA
recommended that firms from the farm
level through the distribution level
undertake these steps.
On March 1, 2006, FDA issued a draft
entitled ‘‘Guide to Minimize Microbial
Food Safety Hazards of Fresh-cut Fruits
and Vegetables’’ (the Fresh-cut Guide)
(Ref. 9). The draft Fresh-cut Guide is
intended to be used in conjunction with
the GAPs/GMPs Guide, which covers
stages prior to fresh-cut processing, with
the current GMPs in part 110 (21 CFR
part 110), which contain food safety
practices applicable to processors who
manufacture, process, pack, or hold
processed food, and with the FDA Food
Code (Ref. 10), which focuses on
activities at subsequent stages, such as
retail. The FDA Food Code gives State
and local governments a scientifically
sound technical and legal basis for
regulating the retail and food service
segment of the industry (restaurants and
grocery stores and institutions such as
nursing homes). State, local, tribal, and
Federal regulators use the FDA Food
Code as a model to develop or update
their own food safety rules and to be
consistent with national food regulatory
policy. (For more information on the
FDA Food Code, see https://
www.cfsan.fda.gov/~dms/
foodcode.html.) FDA is currently
working to finalize the Fresh-cut Guide.
C. Produce Safety Action Plan
In October 2004, FDA issued the
‘‘Produce Safety from Production to
Consumption: 2004 Action Plan to
Minimize Foodborne Illness Associated
with Fresh Produce Consumption’’ or
Produce Safety Action Plan (PSAP) (Ref.
11). The PSAP expands on the areas
covered by the GAPs/GMPs Guide for
farms and packing, to extend to all parts
of the food supply chain from farm
through retail or consumer preparation
and consumption. The PSAP does not
cover frozen fruits and vegetables, fruit
and vegetable juices, or other
commodities, such as tree nuts, that are
neither fruits nor vegetables and not
typically regarded as produce. The
PSAP has four main objectives which
are to: (1) Prevent contamination of
fresh produce with pathogens; (2)
minimize the public health impact
when contamination of fresh produce
occurs; (3) improve communication
with producers, packers, processors,
transporters, distributors, preparers,
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
consumers, and other government
entities about the safety of fresh
produce; and (4) facilitate and support
research relevant to the contamination
of fresh produce. For each objective, the
PSAP identifies steps or actions that
could contribute to the achievement of
that objective. The PSAP has
measurable goals and outcomes, and
several steps outlined in the PSAP are
already in progress or have been
completed. For example, we issued the
draft Fresh-cut Guide as part of the
PSAP objective regarding prevention of
contamination.
D. Partnerships and Collaborations
Because following the GAPs/GMPs
Guide is voluntary, FDA and food safety
partners in the public and private
sectors have stressed education and
outreach to industry to promote
adoption of the guidance. Buyer
requirements that producers and other
suppliers provide self- or third-party
audit verification that they are following
the GAPs/GMPs Guide have further
promoted adoption of the guidance. We
have worked with the fresh produce
industry since the release of the GAPs/
GMPs Guide to promote its
recommendations and to advance the
scientific knowledge applicable to
enhancing the safety of fresh produce.
For example, in conjunction with the
PSAP, we have provided technical
assistance to industry in developing
several commodity specific guidelines
that cover the entire supply chain.
Commodity-specific industry guidelines
exist for three foods: Melons, lettuce
and leafy greens, and tomatoes (see Refs.
12, 13, and 14). An additional industry
guideline on green onions and herbs is
in progress. Between 1996 and 2006,
these commodities together accounted
for approximately 80 percent of the
foodborne outbreaks associated with
produce (Ref. 2).
In August 2006 we launched the
‘‘Lettuce and Leafy Greens Initiative,’’
which involved assessments of practices
and conditions at select farms and
facilities in California. The initiative,
conducted in collaboration with the
California Department of Health
Services and the California Department
of Food and Agriculture, is intended to
be a multi-year effort and may be a
model for other initiatives in the future.
E. Other Food Safety Measures
The provisions in part 110 (Current
Good Manufacturing Practice In
Manufacturing, Packing, Or Holding
Human Food) establish requirements
and recommendations as follows that
apply in determining whether a food is
adulterated: (1) Within the meaning of
E:\FR\FM\27FEN1.SGM
27FEN1
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
cprice-sewell on PROD1PC62 with NOTICES
section 402(a)(3) of the Federal Food,
Drug, and Cosmetic Act (the act) (21
U.S.C. 341(a)(3)), in that the food has
been manufactured under such
conditions that it is unfit for food; or (2)
within the meaning of section 402(a)(4)
of the act, in that the food has been
prepared, packed, or held under
insanitary conditions whereby it may
have become contaminated with filth, or
whereby it may have been rendered
injurious to health. Under § 110.19(a),
establishments engaged solely in the
harvesting, storage, or distribution of
one or more raw agricultural
commodities (as defined in section
201(r) of the act (21 U.S.C. 321)), are not
subject to the requirements of part 110.
However, under § 110.19(b), we may
issue special regulations if it is
necessary to cover these excluded
operations. In addition, the GAPs/GMPs
Guide recommends that operations
excluded from the provisions of part
110 consider implementing the current
GMPs required or recommended in part
110 as appropriate.
For foods other than fresh produce,
we have issued regulations designed to
enhance food safety, including safety
related to microbial pathogens (see, e.g.,
21 CFR part 113, concerning thermally
processed low-acid foods packaged in
hermetically sealed containers; 21 CFR
part 114, concerning acidified foods; 21
CFR 15.51, concerning refrigeration of
shell eggs held for retail distribution; 21
CFR part 120, concerning hazard
analysis and critical control point
(HACCP) systems for juice; and 21 CFR
part 123, concerning HACCP
requirements for fish and fishery
products). Some FDA regulations to
enhance the safety of particular food
products (e.g., the HACCP requirements
in 21 CFR part 120 for juice and in 21
CFR part 123 for fish and fishery
products) contain training and other
requirements for performing particular
functions. For some food products, we
have augmented our regulations with
nonbinding guidance to assist industry
in complying with the regulations (e.g.,
FDA’s Juice HACCP Hazards and
Controls Guidance (available at https://
www.cfsan.fda.gov/~dms/
guidance.html) and Fish And Fisheries
Products Hazards And Controls
Guidance (available at https://
www.cfsan.fda.gov/~dms/
guidance.html)).
F. Next Steps
We believe that the measures outlined
in the PSAP, the GAPs/GMPs Guide,
and other public and private sector
actions, when implemented, have or can
be effective in reducing the risk of
microbial contamination of fresh
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
produce. In particular, the GAPs/GMPs
Guide has been used as a basis for a
number of food safety programs, both in
the United States and internationally.
However, the fact that outbreaks of
foodborne illness associated with fresh
produce continue to occur supports a
close examination of the extent to which
these measures have been implemented;
whether they have been effective, if
implemented properly; and what
additional or different interventions
might be appropriate to reduce the risk
of future outbreaks. As a next step, we
intend to hold two public hearings
regarding the safety of fresh produce.
The purpose and scope of the hearings,
each of which will be governed by part
15 (21 CFR part 15) of FDA’s
regulations, are described in section II of
this document.
II. Purpose and Scope of the Hearings
We want to share information about
recent outbreaks of foodborne illness
associated with microbial
contamination of fresh produce, and to
invite comments, data, and other
scientific information about: Current
agricultural and manufacturing
practices used to produce, harvest, pack,
cool, process, and transport fresh
produce; risk factors for contamination
of fresh produce associated with these
practices; and possible measures by
FDA to enhance the safety of fresh
produce.
This notice describes the scope of the
hearings. We invite information and
comment on the issues and questions in
section III of this document. If you are
interested in these hearings or this
subject, you may address as many of the
following questions as you wish. We do
not expect you to address all questions.
When possible, please provide scientific
information and data in support of your
comments. In addition, to the extent
possible, please provide as specific
information as is feasible about the
estimated costs and benefits associated
with your responses (e.g., the costs and
benefits of current practices and/or the
cost and benefits of any
recommendations you may make).
III. Issues and Questions for Discussion
Issue 1: In the supply chain for fresh
produce (e.g., farms, packing houses,
cooling facilities, and fresh-cut
processing facilities), various factors can
contribute to the risk of microbial
contamination of fresh produce. We
request information to enable us to
identify and understand such factors
more fully.
Question 1. For each stage in the
supply chain, and for each industry
sector, what are the risks or practices
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
8753
that could lead to microbial
contamination of fresh produce?
Question 2. How can or should
current practices be changed to reduce
the risk of contamination?
Question 3. For each stage in the
supply chain, and for each industry
sector, what current practices
(including, for example, following the
GAPs/GMPs Guide) reduce the risk of
microbial contamination of fresh
produce? What data are available to
support a conclusion that the risk of
such contamination is lower than it
would be without the practice in place?
Question 4. Is fresh produce, or inputs
such as agricultural water, sampled and
tested for pathogens or indicator
organisms at any stage of the supply
chain? If yes, please describe the
sampling and testing done.
Issue 2: As described more fully in
sections I.B through I.E of this
document, we already have
implemented several measures to
enhance the safety of fresh produce and
other foods within FDA’s jurisdiction.
Question 5. Beyond the Federal
actions described in sections I.B.
through I.E, what new Federal actions,
if any, are needed to enhance the safety
of fresh produce? On what aspects of the
produce supply chain should the
measures focus?
Question 6. In identifying possible
Federal interventions or actions, to what
extent can or should we take into
account the wide variation within the
fresh produce industry with respect to,
e.g., the size and type of establishments,
the nature of the commodity produced,
the practices used in production, and
the vulnerability of particular
commodities to contamination? To what
extent should such measures apply to
specific products, sectors of the
industry, regions, or businesses? For
example, is there a need for special
treatment for different commodity
groups?
Issue 3: Traceback can be problematic
when unpackaged fresh produce is
involved in an outbreak, especially for
products which may undergo several
packing and repacking steps in the
supply chain with multiple
opportunities for commingling. Even
with respect to packaged and labeled
products, traceback is difficult if there
are insufficient records to identify the
specific farm, field, or block of origin; if
the records lack sufficient specificity
about where the fresh produce went
after leaving the packing or processing
facility; or if there are discrepancies
between records of incoming and
outgoing product.
Question 7. What types of records and
other information, from what types of
E:\FR\FM\27FEN1.SGM
27FEN1
cprice-sewell on PROD1PC62 with NOTICES
8754
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
facilities, are or would be most useful in
facilitating traceback efforts?
Issue 4: Written food safety plans,
sanitation standard operating
procedures (SSOPs), and monitoring
records can serve as useful tools for both
industry and regulators. Such records
can assist operators in conducting
operations in a manner that could
enhance the safety of fresh produce. For
growers, an assessment of factors such
as the field environment and
agricultural inputs could contribute to
the development of written food safety
plans and SSOPs, and also could help
to determine which factors should be
monitored and the frequency of
monitoring. (In the following questions
we use the term ‘‘assessment’’ when
referring to an evaluation conducted by,
or on behalf of, a grower or operator to
identify measures to enhance food
safety.)
Written food safety plans, SSOPs, and
monitoring records also can assist
regulators in verifying that certain
practices are being followed
consistently and properly over time.
Onsite inspections, either alone, or in
conjunction with records review, are
another approach to such verification.
(We use the term ‘‘inspection’’ when
referring to an evaluation conducted by,
or on behalf of, a regulator to evaluate
compliance and the term ‘‘audit’’ to
refer to a self- or third-party evaluation
of whether operations adhere to, for
example, voluntary guidelines or
written food safety plans or SSOPs
developed by the grower, operator, or
buyer.)
Question 8. Are written food safety
plans, written SSOPs, periodic
assessments, training, and/or the
establishment and maintenance of
records useful for risk identification and
risk mitigation or management
purposes? If yes, to what extent are
these practices in place, and in what
sectors of the industry?
Issue 5: As noted in section II.D of
this document, some buyers require that
producers and other suppliers provide
self- or third-party audit verification
that they are following the GAPs/GMPs
Guide. However, the extent to which
these verifications reflect adherence to
the guidance is not well-established.
Question 9. How should adherence to
the GAPs/GMPs Guide or new produce
safety guidance(s) be measured and
verified by the grower or operator,
government regulators, or third-party
auditors, in the event of any new
recommended Federal action or in the
event you are not recommending any
new Federal action?
Question 10. If you are recommending
any new Federal measures, please
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
describe how they might affect certain
small businesses, such as roadside
stands, farm gate operations, farmers’
markets, or other small businesses
involved in direct sales.
IV. Notice of Hearings Under 21 CFR
Part 15
By delegation from the Commissioner
of Food and Drugs (the Commissioner)
(Staff Manual Guide 1420.21, section
1(b)), the Associate Commissioner for
Policy and Planning finds that it is in
the public interest to permit persons to
present information and views at a
public hearing regarding the safety of
fresh produce and is announcing that
the public hearings will be held in
accordance with part 15. The presiding
officer will be the Commissioner or his
designee. The presiding officer will be
accompanied by a panel of FDA
employees with relevant expertise.
Persons who wish to participate in
either hearing (either by making a
presentation or as a member of the
audience) must file a notice of
participation (see ADDRESSES, DATES,
FOR FURTHER INFORMATION CONTACT, and
‘‘How to Participate in the Hearings’’ in
section V of this document). By
delegation from the Commissioner (Staff
Manual Guide 1420.21, section 1(b)), the
Associate Commissioner for Policy and
Planning has determined under
§ 15.20(c) that advance submissions of
oral presentations are necessary for the
panel to formulate useful questions to
be posed at the hearings under
§ 15.30(e), and that the submission of a
comprehensive outline or summary is
an acceptable alternative to the
submission of the full text of the oral
presentation. Because we anticipate
attendance at the hearings to be high,
we request that individuals and
organizations with common interests
consolidate their requests for oral
presentation and request time for a joint
presentation through a single
representative. After reviewing the
notices of participation and
accompanying information, we will
schedule each oral presentation and
notify each participant of the time
allotted to the presenter and the
approximate time that the presentation
is scheduled to begin. If time permits,
we may allow interested persons who
attend one or both hearings but did not
submit a notice of participation in
advance to make an oral presentation at
the conclusion of one or both hearings.
The hearing schedules will be available
at the hearings.
After the hearings, the schedules will
be placed on file in the Division of
Dockets Management (see ADDRESSES)
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
under the docket number listed in
brackets in the heading of this notice.
To ensure timely handling of any
mailed notices of participation,
presentations, or comments, any outer
envelope should be clearly marked with
the docket number listed in brackets in
the heading of this notice along with the
statement ‘‘Safety of Fresh Produce;
Public Hearing.’’
Under § 15.30(f), the hearings are
informal, and the rules of evidence do
not apply. No participant may interrupt
the presentation of another participant.
Only the presiding officer and panel
members may question any person
during or at the conclusion of each
presentation.
Public hearings under part 15 are
subject to FDA’s policy and procedures
for electronic media coverage of FDA’s
public administrative proceedings (part
10 (21 CFR part 10, subpart C)). Under
§ 10.205, representatives of the
electronic media may be permitted,
subject to the procedures and
limitations in § 10.206, to videotape,
film, or otherwise record FDA’s public
administrative proceedings, including
presentations by participants. The
hearings will be transcribed as
stipulated in § 15.30(b). The transcript
will be available on the Internet at
https://www.fda.gov/ohrms/dockets/
default.htm, and orders for copies of the
transcript can be placed at the hearing
or through the Division of Dockets
Management (see ADDRESSES).
Any handicapped persons requiring
special accommodations to attend the
hearings should direct those needs to
the contact person (see FOR FURTHER
INFORMATION CONTACT).
To the extent that the conditions for
the hearings, as described in this notice,
conflict with any provisions set out in
part 15, this notice acts as a waiver of
these provisions as specified in §§ 10.19
and 15.30(h). In particular, § 15.21(a)
states that the notice of hearing will
provide persons an opportunity to file a
written notice of participation with the
Division of Dockets Management within
a specified period of time. If the public
interest requires, e.g., if a hearing is to
be conducted within a short period of
time, the notice may name a specific
FDA employee and telephone number to
whom an oral notice of participation
may be given. If the public interest
requires, the notice may also provide for
submitting notices of participation at
the time of the hearing. In this
document, the conditions for the
hearings specify that notices of
participation be submitted
electronically to an agency Internet site,
to a contact person (outside of FDA)
who will accept notices of participation
E:\FR\FM\27FEN1.SGM
27FEN1
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
cprice-sewell on PROD1PC62 with NOTICES
by mail, telephone, fax, or e-mail, or in
person on the day of the hearing (as
space permits). We are using these
procedures for submitting notices of
participation, rather than provide for the
submission of notices of participation to
the Division of Dockets Management,
because the hearing is to be conducted
within a short period of time and these
procedures are more efficient. In
addition, these procedures provide more
flexibility to persons who wish to
participate in the hearings than would
be provided if participants were
required to submit the notice of
participation in writing to the Division
of Dockets Management. By delegation
from the Commissioner (Staff Manual
Guide 1420.21, section 1(f)(2)(i)), the
Associate Commissioner for Policy and
Planning finds under § 10.19 that no
participant will be prejudiced, the ends
of justice will thereby be served, and the
action is in accordance with law if
notices of participation are submitted by
the procedures listed in this notice
rather than to the Division of Dockets
Management.
V. How to Participate in the Hearings
Registration by submission of a notice
of participation is necessary to ensure
participation and will be accepted on a
first-come, first-served basis. The notice
of participation may be submitted
electronically (see ADDRESSES). The
notice of participation also may be
submitted orally, by fax, or by e-mail
(see ADDRESSES and FOR FURTHER
INFORMATION CONTACT). We encourage
you to submit your notice of
participation electronically. A single
copy of any notice of participation is
sufficient, except that any person who
wishes to participate in both hearings
must submit a separate notice of
participation for each hearing.
The notice of participation must
include your name, title, business
affiliation (if applicable), address,
telephone number, fax number (if
available), and e-mail address (if
available). If you wish to request an
opportunity to make an oral
presentation during the open public
comment period of the hearing, your
notice of participation also must include
the title of your presentation, the
sponsor of the oral presentation (e.g.,
the organization paying travel expenses
or fees), if any; and the approximate
amount of time requested for the
presentation. Presentations will be
limited to the questions and subject
matter identified in section III of this
document, and, depending on the
number of requests received, we may be
obliged to limit the time allotted for
each presentation.
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
Persons who wish to request an
opportunity to make an oral
presentation at the March 20, 2007,
public hearing must submit a notice of
participation (register) by March 2,
2007. All other persons wishing to
register to attend the March 20, 2007,
public hearing must submit a notice of
participation by March 12, 2007.
Persons who request an opportunity to
make an oral presentation at the March
20, 2007, public hearing also must
submit either the full text of the oral
presentation, or a comprehensive
outline or summary of the oral
presentation, by March 12, 2007.
Persons requiring special
accommodations due to a disability
must register by March 6, 2007.
Persons who wish to request an
opportunity to make an oral
presentation at the April 13, 2007,
public hearing must submit a notice of
participation by March 23, 2007. All
other persons wishing to register to
attend the April 13, 2007, public
hearing must submit a notice of
participation by April 6, 2007. Persons
who request an opportunity to make an
oral presentation at the second public
hearing also must submit either the full
text of the oral presentation, or a
comprehensive outline or summary of
the oral presentation, by April 6, 2007.
Under § 15.20(c), if you request an
opportunity to make an oral
presentation you must submit your
presentation (either as the full text of
the presentation, or as a comprehensive
outline or summary) by e-mail or by fax.
See ADDRESSES and FOR FURTHER
INFORMATION CONTACT for information on
where to send your presentation.
Individuals who request an
opportunity to make an oral
presentation will be notified of the
scheduled time for their presentation
prior to the hearing. Depending on the
number of oral presentations, we may
need to limit the time allotted for each
oral presentation (e.g., 5 minutes each).
As stated earlier, we request that
interested persons and groups having
similar interests consolidate their
requests for oral presentation and
present them through a single
representative. If you need special
accommodations due to a disability,
please inform us (see FOR FURTHER
INFORMATION CONTACT).
We will also accept registration
onsite; however, space is limited and
will be closed when the maximum
seating capacity is reached. If space is
available, on-site registration will be
accepted on a first-come, first-served
basis. Requests for an opportunity to
make a presentation from individuals or
organizations that did not register to
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
8755
make an oral presentation may be
granted if time permits.
Persons who registered for the hearing
should check in at the on-site
registration desk between 8:30 and 9
a.m. Persons who wish to register onsite
on the day of the hearing should do so
at the registration desk between 8:30
and 9 a.m. We encourage all
participants to attend the entire day.
Because the hearings will be held in
Federal buildings, hearing participants
must present photo identification and
plan adequate time to pass through the
security system.
VI. Request for Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments in response to this document
and notice of hearings for consideration
at or after the hearings in addition to, or
in place of, a request for an opportunity
to make an oral presentation (see section
V of this document). Submit two paper
copies of any written comments, except
that individuals may submit one copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
FDA is inviting public comment in
writing and at the public hearings.
These comments are sought to inform
FDA decisionmaking about possible
regulatory action with respect to the
safety of fresh produce. Written or
electronic comments (i.e., submissions
other than notices of participation and
the text, comprehensive outline, or
summary of an oral presentation) may
be submitted until June 13, 2007. The
administrative record of the hearing will
remain open until June 13, 2007.
VII. References
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday. (FDA has verified the
Web site addresses, but FDA is not
responsible for any subsequent changes
to the Web sites after this document
publishes in the Federal Register.
1. Sivapalasingam, S., et al. ‘‘Fresh
Produce: A Growing Cause of Outbreaks of
Foodborne Illness in the United States, 1973
through 1997,’’ Journal of Food Protection
67(10): 2342–53, 2004.
2. U.S. Food and Drug Administration,
1996–2006 Produce Outbreaks (unpublished
compilation).
3. U.S. Food and Drug Administration,
FDA News Release, ‘‘FDA Warning on
Serious Foodborne E. coli O157:H7
E:\FR\FM\27FEN1.SGM
27FEN1
cprice-sewell on PROD1PC62 with NOTICES
8756
Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
Outbreak,’’ P06–131, September 14, 2006,
available at https://www.fda.gov/po/indexes/
2006news.html.
4. U.S. Centers for Disease Control and
Prevention, ‘‘Update on Multi-State Outbreak
of E. coli O157:H7 Infections From Fresh
Spinach, October 6, 2006, available at https://
www.cdc.gov/ecoli/2006/september/updates/
100606.htm.
5. U.S. Department of Health and Human
Services and U.S. Department of Agriculture,
‘‘Dietary Guidelines for Americans 2005,’’
January 2005, available at https://
www.healthierus.gov/dietaryguidelines/.
6. U.S. Food and Drug Administration,
‘‘Guide to Minimize Microbial Food Safety
Hazards for Fresh Fruits and Vegetables,’’
October 26, 1998, available at https://
www.cfsan.fda.gov/~dms/prodguid.html.
7. U.S. Food and Drug Administration,
Center for Food Safety and Applied
Nutrition, Office of Plant and Dairy Foods,
‘‘Letter to Firms that Grow, Pack, or Ship
Fresh Lettuce and Fresh Tomatoes,’’ February
5, 2004, available at https://
www.cfsan.fda.gov/~dms/prodltr.html.
8. U.S. Food and Drug Administration,
Center for Food Safety and Applied
Nutrition, Office of Plant and Dairy Foods,
‘‘Letter to California Firms that Grow, Pack,
Process, or Ship Fresh and Fresh-cut
Lettuce,’’ November 4, 2005, available at
https://www.cfsan.fda.gov/~dms/
prodltr2.html.
9. U.S. Food and Drug Administration,
‘‘Guide to Minimize Microbial Food Safety
Hazards of Fresh-Cut Fruits and Vegetables,’’
March 2006, available at https://
www.cfsan.fda.gov/~dms/prodgui2.html.
10. U.S. Department of Health and Human
Services, Public Health Service, Food and
Drug Administration, FDA Food Code, 2005,
available at https://www.cfsan.fda.gov/~dms/
foodcode.html.
11. U.S. Food and Drug Administration,
‘‘Produce Safety from Production to
Consumption: 2004 Action Plan to Minimize
Foodborne Illness Associated With Fresh
Produce Consumption,’’ October 2004,
available at https://www.cfsan.fda.gov/~dms/
prodpla2.html.
12. Produce Marketing Association and
United Fresh Fruit and Vegetable
Association, ‘‘Commodity Specific Food
Safety Guidelines for the Melon Supply
Chain,’’ November 7, 2005, available at
https://www.cfsan.fda.gov/~dms/
melonsup.html or https://www.cfsan.fda.gov/
~acrobat/melonsup.pdf.
13. International Fresh-Cut Produce
Association, Produce Marketing Association,
United Fresh Fruit and Vegetable
Association, Western Growers Association;
Commodity Specific Food Safety Guidelines
for the Lettuce and Leafy Greens Supply
Chain; April 25, 2006, available at https://
www.cfsan.fda.gov/~dms/lettsup.html or
https://www.cfsan.fda.gov/~acrobat/
lettsup.pdf.
14. North American Tomato Trade Work
Group, ‘‘Commodity Specific Food Safety
Guidelines for the Fresh Tomato Supply
Chain, May 2006, available at https://
www.cfsan.fda.gov/~dms/tomatsup.html or
https://www.cfsan.fda.gov/~acrobat/
tomatsup.pdf.
VerDate Aug<31>2005
15:22 Feb 26, 2007
Jkt 211001
Dated: February 21, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. 07–891 Filed 2–23–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006D–0480]
Draft Guidance for Industry on
Complementary and Alternative
Medicine Products and Their
Regulation by the Food and Drug
Administration; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance for
industry entitled ‘‘Complementary and
Alternative Medicine Products and
Their Regulation by the Food and Drug
Administration.’’ In recent years, the
practice of complementary and
alternative medicine (CAM) has
increased in the United States, and we
have seen increased confusion as to
whether certain products used in CAM
are subject to regulation under the
Federal Food, Drug, and Cosmetic Act
(the act) or Public Health Service Act
(PHS Act). We have also seen an
increase in the number of CAM
products imported into the United
States. Therefore, the draft guidance
discusses when a CAM product is
subject to the act or the PHS Act.
DATES: Submit written or electronic
comments on the draft guidance by
April 30, 2007. General comments on
agency guidance documents are
welcome at any time.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Office of Communication, Training, and
Manufacturers Assistance (HFM–40),
Center for Biologics Evaluation and
Research, Food and Drug
Administration, 1401 Rockville Pike,
suite 200N Rockville, MD 20852–1448.
Send one self-addressed adhesive label
to assist that office in processing your
requests. Submit written comments on
the draft guidance to the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, rm. 1061, Rockville, MD 20852.
Submit electronic comments to https://
www.fda.gov/dockets/ecomments. See
the SUPPLEMENTARY INFORMATION section
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
for electronic access to the draft
guidance document.
FOR FURTHER INFORMATION CONTACT:
Philip L. Chao, Office of Policy and
Planning (HF–23), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–0587.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a draft guidance for industry entitled
‘‘Complementary and Alternative
Medicine Products and Their Regulation
by the Food and Drug Administration.’’
The term ‘‘complementary and
alternative medicine’’ (CAM)
encompasses a wide array of health care
practices, products, and therapies that
are distinct from practices, products,
and therapies used in ‘‘conventional’’ or
‘‘allopathic’’ medicine.
In the United States, the practice of
CAM has risen dramatically in recent
years. In 1992, Congress established the
Office of Unconventional Therapies,
which later became the Office of
Alternative Medicine (OAM), to explore
‘‘unconventional medical practices.’’ In
1998, OAM became the National Center
for Complementary and Alternative
Medicine (NCCAM). NCCAM is a center
within the National Institutes of Health.
The Institute of Medicine, in its book
entitled, Complementary and
Alternative Medicine in the United
States, stated that more than one-third
of American adults reported using some
form of CAM and that visits to CAM
providers each year exceed those to
primary care physicians (see Institute of
Medicine, Complementary and
Alternative Medicine in the United
States, pages 34 through 35 (2005)).
As the practice of CAM has increased
in the United States, we have seen
increased confusion as to whether
certain products used in CAM (which,
for convenience, we will refer to as
‘‘CAM products’’) are subject to
regulation under the act or the PHS Act.
We have also seen an increase in the
number of CAM products imported into
the United States. Therefore, the draft
guidance discusses when a CAM
product is subject to the act or the PHS
Act. (When the draft guidance mentions
a particular CAM therapy, practice, or
product, it does so in order to provide
background information or to serve as
an example or illustration; any mention
of a particular CAM therapy, practice, or
product should not be construed as
expressing FDA’s support for or
endorsement of that particular CAM
therapy, practice, or product or, unless
specified otherwise, as an agency
determination that a particular product
E:\FR\FM\27FEN1.SGM
27FEN1
Agencies
[Federal Register Volume 72, Number 38 (Tuesday, February 27, 2007)]
[Notices]
[Pages 8750-8756]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-891]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N-0051]
Safety of Fresh Produce; Public Hearings; Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public hearings; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing two
public hearings concerning the safety of fresh produce. The purpose of
the hearings is for FDA to share information about recent outbreaks of
foodborne illness associated with microbial contamination of fresh
produce, and to solicit comments, data, and other scientific
information about current agricultural and manufacturing practices used
to produce, harvest, pack, cool, process, and transport fresh produce;
risk factors for contamination of fresh produce associated with these
practices; and possible measures by FDA to enhance the safety of fresh
produce.
DATES: The first public hearing will be held on March 20, 2007, from 9
a.m. to
[[Page 8751]]
5 p.m. The second public hearing will be held on April 13, 2007, from 9
a.m. to 5 p.m. See section V of this document for additional dates on
how to participate in the hearings. Submit written or electronic
comments (i.e., submissions other than notices of participation and the
text, comprehensive outline, or summary of an oral presentation) by
June 13, 2007.
ADDRESSES: The first public hearing will be held at the Ronald V.
Dellums Federal Building, Edward Roybal Auditorium, 1301 Clay St., 3d
floor, Oakland, CA 94612. The second public hearing will be held at the
Harvey W. Wiley Federal Building, Food and Drug Administration, Center
for Food Safety and Applied Nutrition, 5100 Paint Branch Pkwy., College
Park, MD, 20740-3835 (Metro stop: College Park on the Green Line).
Submit electronic notices of participation for either hearing to
https://www.cfsan.fda.gov/~comm/register.html. We encourage you to use
this method of registration, if possible. You may also submit oral or
written notices of participation by phone, by fax, or by e-mail, or
submit the written full text, comprehensive outline, or summary of any
oral presentation by fax or by e-mail to Isabelle Howes, U.S.
Department of Agriculture Graduate School, 202-314-4713, FAX: 202-479-
6801, or e-mail: Isabelle--Howes@grad.usda.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. Submit electronic comments to https://www.fda.gov/
dockets/ecomments.
Instructions: All submissions and comments received must include
the agency name and docket number found in brackets in the heading of
this document. All submissions and comments received may be posted
without change to https://www.fda.gov/ohrms/dockets/default.htm,
including any personal information provided. For additional information
on submitting comments, see section VI in the SUPPLEMENTARY INFORMATION
section of this document.
Transcripts of the hearings will be available for review at the
Division of Dockets Management and on the Internet at https://
www.fda.gov/ohrms/dockets/default.htm approximately 30 days after the
hearing.
FOR FURTHER INFORMATION CONTACT:
To submit an oral or written notice of participation by phone, by
fax, or by e-mail, or the written full text, comprehensive outline, or
summary of any oral presentation by fax or by e-mail: Isabelle Howes,
U.S. Department of Agriculture Graduate School, 202-314-4713, FAX: 202-
479-6801, or e-mail: Isabelle--Howes@grad.usda.gov. All participants
must complete registration. Following registration, you will receive a
confirmation notice which also includes hotel and parking information.
For all other questions about the hearings or if you need special
accommodations due to a disability: Juanita Yates, Center for Food
Safety and Applied Nutrition, Food and Drug Administration, 301-436-
1731, e-mail: Juanita.Yates@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
A. Food Safety and Fresh Produce
FDA is responsible for ensuring the safety of all domestic and
imported fresh and fresh-cut fruits and vegetables consumed in the
United States. Fresh fruits and vegetables are those that are likely to
be sold to consumers in an unprocessed or minimally processed (i.e.,
raw) form. Fresh fruits and vegetables may be intact and whole, such as
whole apples, or cut in the act of harvest, such as heads of lettuce
and bunches of broccoli. As used in this document, the term ``fresh-cut
produce'' refers to minimally processed fruits and vegetables that have
been altered in form by peeling, slicing, chopping, shredding, coring,
or trimming, with or without washing or other treatment, prior to being
packaged for use by the consumer or retail establishment. Examples of
fresh-cut products are shredded lettuce, sliced tomatoes, salad mixes,
peeled baby carrots, broccoli florets, and cut melons. Fresh-cut
produce does not require additional preparation, processing, or cooking
before consumption, with the possible exception of washing or the
addition of salad dressing or seasoning. In this document, we use the
term ``fresh produce'' to describe all fresh and fresh-cut fruits and
vegetables consumed in the United States.
Because most fresh produce is grown in a natural environment, it is
vulnerable to contamination with pathogens (i.e., bacteria or other
organisms that can cause disease). Factors that may affect the
occurrence of such contamination include agricultural and/or processing
water quality, the use of manure as fertilizer, the presence of wild or
domestic animals in or near fields or packing areas, worker health and
hygiene, environmental conditions, production activities, and equipment
and facility sanitation. Consequently, the manner in which fresh
produce is grown, harvested, packed, processed, transported,
distributed, and prepared is crucial to minimizing the risk of
microbial contamination. (We use the term ``microbial contamination''
to refer to contamination with any microorganism.)
Data reported to the U.S. Centers for Disease Control and
Prevention (CDC) indicate that between 1973 and 1997 reported outbreaks
of foodborne illness in the United States associated with fresh produce
increased in absolute numbers and as a proportion of all reported
foodborne outbreaks (Ref. 1). (By ``outbreak,'' we mean the occurrence
of two or more cases of a similar illness resulting from the ingestion
of a common food.) Unpublished data compiled by FDA indicate that from
1996 to 2006 there were approximately 72 reported outbreaks of
foodborne illness associated with approximately 20 fresh produce
commodities. Of this total, 12 outbreaks were associated with tomatoes,
11 outbreaks were associated with melons, and 24 outbreaks were
associated with leafy greens such as lettuce and spinach (Ref. 2).
These outbreaks involved a number of pathogens, including Escherichia
coli (E. coli) O157:H7 and Salmonella species, and both domestic and
imported produce. These totals include only those outbreaks in which
our investigation has indicated that the contamination of the produce
was not a result of exposure to an infected food handler or other
unsafe food handling practice at the place of preparation and
consumption (i.e., home or restaurant).
When there is an outbreak of foodborne illness, we work with
Federal, State, and local agencies to identify the source of the
outbreak and minimize the public health impact. For example, on
September 14, 2006, we issued a news release alerting consumers about
an outbreak of E. coli O157:H7 in multiple States and advising the
public not to eat bagged fresh spinach because it had been implicated
in the outbreak (Ref. 3). We continued to issue updated press releases
for approximately four weeks. During the course of the outbreak,
approximately 200 illnesses were reported to the CDC, including more
than 30 cases of hemolytic uremic syndrome (HUS, a condition occurring
mainly in children that can result in kidney failure), more than 100
hospitalizations, and 3 deaths (Ref. 4). In addition to working to
identify the food involved in the outbreak, we worked with others to
trace the source of the implicated
[[Page 8752]]
product to packing, cooling and processing facilities involved and to
the farm to identify practices or conditions that may have contributed
to the contamination of the produce.
One challenge faced by public health officials during an outbreak
is to quickly identify through traceback the sources of contamination.
FDA's regulations require the establishment and maintenance of records
by persons who manufacture, process, pack, transport, distribute,
receive, hold, or import food in the United States (21 CFR 1.326-
1.368). Such records allow for the identification of the immediate
previous sources and immediate subsequent recipients of food, and
thereby help FDA and other authorities determine the source and cause
of the event. Farms and restaurants are excluded from these
requirements. Traceback can be particularly problematic when fresh
produce is involved.
Eating fruits and vegetables is an important part of a healthy diet
(Ref. 5). We place a high priority on identifying and implementing
measures that can reduce the incidence of foodborne illness associated
with fresh produce.
B. Guidance Documents and Letters Issued by FDA to Enhance the Safety
of Fresh Produce
In 1998, FDA issued guidance to industry entitled ``Guide to
Minimize Microbial Food Safety Hazards for Fresh Fruits and
Vegetables'' (GAPs/GMPs Guide) (Ref. 6). This guide recommends good
agricultural practices (GAPs) and good manufacturing practices (GMPs)
that growers, packers, and shippers can undertake to address common
risk factors in their operations and thereby minimize food safety
hazards potentially associated with fresh produce. Implementation of
risk reduction measures is critical; as the GAPs/GMPs Guide notes,
current technologies cannot eliminate all potential food safety hazards
associated with fresh produce that will be eaten raw.
On February 5, 2004, FDA issued a letter to firms that grow, pack,
or ship fresh lettuce and fresh tomatoes, expressing concern regarding
outbreaks of foodborne illness associated with the consumption of fresh
lettuce and fresh tomatoes, and recommending actions to enhance the
safety of these products (Ref. 7). On November 4, 2005, FDA issued a
second letter to firms that grow, pack, process or ship fresh and
fresh-cut lettuce, reiterating concerns about continuing outbreaks
(Ref. 8). In the November 2005 letter, FDA strongly encouraged
applicable firms to review their current operations in light of the
GAPs\GMPs Guide, as well as other available information regarding the
reduction or elimination of pathogens on fresh produce. FDA encouraged
firms to consider modifying their operations to ensure that they were
taking the appropriate measures to provide a safe product to the
consumer. FDA recommended that firms from the farm level through the
distribution level undertake these steps.
On March 1, 2006, FDA issued a draft entitled ``Guide to Minimize
Microbial Food Safety Hazards of Fresh-cut Fruits and Vegetables'' (the
Fresh-cut Guide) (Ref. 9). The draft Fresh-cut Guide is intended to be
used in conjunction with the GAPs/GMPs Guide, which covers stages prior
to fresh-cut processing, with the current GMPs in part 110 (21 CFR part
110), which contain food safety practices applicable to processors who
manufacture, process, pack, or hold processed food, and with the FDA
Food Code (Ref. 10), which focuses on activities at subsequent stages,
such as retail. The FDA Food Code gives State and local governments a
scientifically sound technical and legal basis for regulating the
retail and food service segment of the industry (restaurants and
grocery stores and institutions such as nursing homes). State, local,
tribal, and Federal regulators use the FDA Food Code as a model to
develop or update their own food safety rules and to be consistent with
national food regulatory policy. (For more information on the FDA Food
Code, see https://www.cfsan.fda.gov/~dms/foodcode.html.) FDA is
currently working to finalize the Fresh-cut Guide.
C. Produce Safety Action Plan
In October 2004, FDA issued the ``Produce Safety from Production to
Consumption: 2004 Action Plan to Minimize Foodborne Illness Associated
with Fresh Produce Consumption'' or Produce Safety Action Plan (PSAP)
(Ref. 11). The PSAP expands on the areas covered by the GAPs/GMPs Guide
for farms and packing, to extend to all parts of the food supply chain
from farm through retail or consumer preparation and consumption. The
PSAP does not cover frozen fruits and vegetables, fruit and vegetable
juices, or other commodities, such as tree nuts, that are neither
fruits nor vegetables and not typically regarded as produce. The PSAP
has four main objectives which are to: (1) Prevent contamination of
fresh produce with pathogens; (2) minimize the public health impact
when contamination of fresh produce occurs; (3) improve communication
with producers, packers, processors, transporters, distributors,
preparers, consumers, and other government entities about the safety of
fresh produce; and (4) facilitate and support research relevant to the
contamination of fresh produce. For each objective, the PSAP identifies
steps or actions that could contribute to the achievement of that
objective. The PSAP has measurable goals and outcomes, and several
steps outlined in the PSAP are already in progress or have been
completed. For example, we issued the draft Fresh-cut Guide as part of
the PSAP objective regarding prevention of contamination.
D. Partnerships and Collaborations
Because following the GAPs/GMPs Guide is voluntary, FDA and food
safety partners in the public and private sectors have stressed
education and outreach to industry to promote adoption of the guidance.
Buyer requirements that producers and other suppliers provide self- or
third-party audit verification that they are following the GAPs/GMPs
Guide have further promoted adoption of the guidance. We have worked
with the fresh produce industry since the release of the GAPs/GMPs
Guide to promote its recommendations and to advance the scientific
knowledge applicable to enhancing the safety of fresh produce. For
example, in conjunction with the PSAP, we have provided technical
assistance to industry in developing several commodity specific
guidelines that cover the entire supply chain. Commodity-specific
industry guidelines exist for three foods: Melons, lettuce and leafy
greens, and tomatoes (see Refs. 12, 13, and 14). An additional industry
guideline on green onions and herbs is in progress. Between 1996 and
2006, these commodities together accounted for approximately 80 percent
of the foodborne outbreaks associated with produce (Ref. 2).
In August 2006 we launched the ``Lettuce and Leafy Greens
Initiative,'' which involved assessments of practices and conditions at
select farms and facilities in California. The initiative, conducted in
collaboration with the California Department of Health Services and the
California Department of Food and Agriculture, is intended to be a
multi-year effort and may be a model for other initiatives in the
future.
E. Other Food Safety Measures
The provisions in part 110 (Current Good Manufacturing Practice In
Manufacturing, Packing, Or Holding Human Food) establish requirements
and recommendations as follows that apply in determining whether a food
is adulterated: (1) Within the meaning of
[[Page 8753]]
section 402(a)(3) of the Federal Food, Drug, and Cosmetic Act (the act)
(21 U.S.C. 341(a)(3)), in that the food has been manufactured under
such conditions that it is unfit for food; or (2) within the meaning of
section 402(a)(4) of the act, in that the food has been prepared,
packed, or held under insanitary conditions whereby it may have become
contaminated with filth, or whereby it may have been rendered injurious
to health. Under Sec. 110.19(a), establishments engaged solely in the
harvesting, storage, or distribution of one or more raw agricultural
commodities (as defined in section 201(r) of the act (21 U.S.C. 321)),
are not subject to the requirements of part 110. However, under Sec.
110.19(b), we may issue special regulations if it is necessary to cover
these excluded operations. In addition, the GAPs/GMPs Guide recommends
that operations excluded from the provisions of part 110 consider
implementing the current GMPs required or recommended in part 110 as
appropriate.
For foods other than fresh produce, we have issued regulations
designed to enhance food safety, including safety related to microbial
pathogens (see, e.g., 21 CFR part 113, concerning thermally processed
low-acid foods packaged in hermetically sealed containers; 21 CFR part
114, concerning acidified foods; 21 CFR 15.51, concerning refrigeration
of shell eggs held for retail distribution; 21 CFR part 120, concerning
hazard analysis and critical control point (HACCP) systems for juice;
and 21 CFR part 123, concerning HACCP requirements for fish and fishery
products). Some FDA regulations to enhance the safety of particular
food products (e.g., the HACCP requirements in 21 CFR part 120 for
juice and in 21 CFR part 123 for fish and fishery products) contain
training and other requirements for performing particular functions.
For some food products, we have augmented our regulations with
nonbinding guidance to assist industry in complying with the
regulations (e.g., FDA's Juice HACCP Hazards and Controls Guidance
(available at https://www.cfsan.fda.gov/~dms/guidance.html) and Fish And
Fisheries Products Hazards And Controls Guidance (available at https://
www.cfsan.fda.gov/~dms/guidance.html)).
F. Next Steps
We believe that the measures outlined in the PSAP, the GAPs/GMPs
Guide, and other public and private sector actions, when implemented,
have or can be effective in reducing the risk of microbial
contamination of fresh produce. In particular, the GAPs/GMPs Guide has
been used as a basis for a number of food safety programs, both in the
United States and internationally. However, the fact that outbreaks of
foodborne illness associated with fresh produce continue to occur
supports a close examination of the extent to which these measures have
been implemented; whether they have been effective, if implemented
properly; and what additional or different interventions might be
appropriate to reduce the risk of future outbreaks. As a next step, we
intend to hold two public hearings regarding the safety of fresh
produce. The purpose and scope of the hearings, each of which will be
governed by part 15 (21 CFR part 15) of FDA's regulations, are
described in section II of this document.
II. Purpose and Scope of the Hearings
We want to share information about recent outbreaks of foodborne
illness associated with microbial contamination of fresh produce, and
to invite comments, data, and other scientific information about:
Current agricultural and manufacturing practices used to produce,
harvest, pack, cool, process, and transport fresh produce; risk factors
for contamination of fresh produce associated with these practices; and
possible measures by FDA to enhance the safety of fresh produce.
This notice describes the scope of the hearings. We invite
information and comment on the issues and questions in section III of
this document. If you are interested in these hearings or this subject,
you may address as many of the following questions as you wish. We do
not expect you to address all questions. When possible, please provide
scientific information and data in support of your comments. In
addition, to the extent possible, please provide as specific
information as is feasible about the estimated costs and benefits
associated with your responses (e.g., the costs and benefits of current
practices and/or the cost and benefits of any recommendations you may
make).
III. Issues and Questions for Discussion
Issue 1: In the supply chain for fresh produce (e.g., farms,
packing houses, cooling facilities, and fresh-cut processing
facilities), various factors can contribute to the risk of microbial
contamination of fresh produce. We request information to enable us to
identify and understand such factors more fully.
Question 1. For each stage in the supply chain, and for each
industry sector, what are the risks or practices that could lead to
microbial contamination of fresh produce?
Question 2. How can or should current practices be changed to
reduce the risk of contamination?
Question 3. For each stage in the supply chain, and for each
industry sector, what current practices (including, for example,
following the GAPs/GMPs Guide) reduce the risk of microbial
contamination of fresh produce? What data are available to support a
conclusion that the risk of such contamination is lower than it would
be without the practice in place?
Question 4. Is fresh produce, or inputs such as agricultural water,
sampled and tested for pathogens or indicator organisms at any stage of
the supply chain? If yes, please describe the sampling and testing
done.
Issue 2: As described more fully in sections I.B through I.E of
this document, we already have implemented several measures to enhance
the safety of fresh produce and other foods within FDA's jurisdiction.
Question 5. Beyond the Federal actions described in sections I.B.
through I.E, what new Federal actions, if any, are needed to enhance
the safety of fresh produce? On what aspects of the produce supply
chain should the measures focus?
Question 6. In identifying possible Federal interventions or
actions, to what extent can or should we take into account the wide
variation within the fresh produce industry with respect to, e.g., the
size and type of establishments, the nature of the commodity produced,
the practices used in production, and the vulnerability of particular
commodities to contamination? To what extent should such measures apply
to specific products, sectors of the industry, regions, or businesses?
For example, is there a need for special treatment for different
commodity groups?
Issue 3: Traceback can be problematic when unpackaged fresh produce
is involved in an outbreak, especially for products which may undergo
several packing and repacking steps in the supply chain with multiple
opportunities for commingling. Even with respect to packaged and
labeled products, traceback is difficult if there are insufficient
records to identify the specific farm, field, or block of origin; if
the records lack sufficient specificity about where the fresh produce
went after leaving the packing or processing facility; or if there are
discrepancies between records of incoming and outgoing product.
Question 7. What types of records and other information, from what
types of
[[Page 8754]]
facilities, are or would be most useful in facilitating traceback
efforts?
Issue 4: Written food safety plans, sanitation standard operating
procedures (SSOPs), and monitoring records can serve as useful tools
for both industry and regulators. Such records can assist operators in
conducting operations in a manner that could enhance the safety of
fresh produce. For growers, an assessment of factors such as the field
environment and agricultural inputs could contribute to the development
of written food safety plans and SSOPs, and also could help to
determine which factors should be monitored and the frequency of
monitoring. (In the following questions we use the term ``assessment''
when referring to an evaluation conducted by, or on behalf of, a grower
or operator to identify measures to enhance food safety.)
Written food safety plans, SSOPs, and monitoring records also can
assist regulators in verifying that certain practices are being
followed consistently and properly over time. Onsite inspections,
either alone, or in conjunction with records review, are another
approach to such verification. (We use the term ``inspection'' when
referring to an evaluation conducted by, or on behalf of, a regulator
to evaluate compliance and the term ``audit'' to refer to a self- or
third-party evaluation of whether operations adhere to, for example,
voluntary guidelines or written food safety plans or SSOPs developed by
the grower, operator, or buyer.)
Question 8. Are written food safety plans, written SSOPs, periodic
assessments, training, and/or the establishment and maintenance of
records useful for risk identification and risk mitigation or
management purposes? If yes, to what extent are these practices in
place, and in what sectors of the industry?
Issue 5: As noted in section II.D of this document, some buyers
require that producers and other suppliers provide self- or third-party
audit verification that they are following the GAPs/GMPs Guide.
However, the extent to which these verifications reflect adherence to
the guidance is not well-established.
Question 9. How should adherence to the GAPs/GMPs Guide or new
produce safety guidance(s) be measured and verified by the grower or
operator, government regulators, or third-party auditors, in the event
of any new recommended Federal action or in the event you are not
recommending any new Federal action?
Question 10. If you are recommending any new Federal measures,
please describe how they might affect certain small businesses, such as
roadside stands, farm gate operations, farmers' markets, or other small
businesses involved in direct sales.
IV. Notice of Hearings Under 21 CFR Part 15
By delegation from the Commissioner of Food and Drugs (the
Commissioner) (Staff Manual Guide 1420.21, section 1(b)), the Associate
Commissioner for Policy and Planning finds that it is in the public
interest to permit persons to present information and views at a public
hearing regarding the safety of fresh produce and is announcing that
the public hearings will be held in accordance with part 15. The
presiding officer will be the Commissioner or his designee. The
presiding officer will be accompanied by a panel of FDA employees with
relevant expertise.
Persons who wish to participate in either hearing (either by making
a presentation or as a member of the audience) must file a notice of
participation (see ADDRESSES, DATES, FOR FURTHER INFORMATION CONTACT,
and ``How to Participate in the Hearings'' in section V of this
document). By delegation from the Commissioner (Staff Manual Guide
1420.21, section 1(b)), the Associate Commissioner for Policy and
Planning has determined under Sec. 15.20(c) that advance submissions
of oral presentations are necessary for the panel to formulate useful
questions to be posed at the hearings under Sec. 15.30(e), and that
the submission of a comprehensive outline or summary is an acceptable
alternative to the submission of the full text of the oral
presentation. Because we anticipate attendance at the hearings to be
high, we request that individuals and organizations with common
interests consolidate their requests for oral presentation and request
time for a joint presentation through a single representative. After
reviewing the notices of participation and accompanying information, we
will schedule each oral presentation and notify each participant of the
time allotted to the presenter and the approximate time that the
presentation is scheduled to begin. If time permits, we may allow
interested persons who attend one or both hearings but did not submit a
notice of participation in advance to make an oral presentation at the
conclusion of one or both hearings. The hearing schedules will be
available at the hearings.
After the hearings, the schedules will be placed on file in the
Division of Dockets Management (see ADDRESSES) under the docket number
listed in brackets in the heading of this notice.
To ensure timely handling of any mailed notices of participation,
presentations, or comments, any outer envelope should be clearly marked
with the docket number listed in brackets in the heading of this notice
along with the statement ``Safety of Fresh Produce; Public Hearing.''
Under Sec. 15.30(f), the hearings are informal, and the rules of
evidence do not apply. No participant may interrupt the presentation of
another participant. Only the presiding officer and panel members may
question any person during or at the conclusion of each presentation.
Public hearings under part 15 are subject to FDA's policy and
procedures for electronic media coverage of FDA's public administrative
proceedings (part 10 (21 CFR part 10, subpart C)). Under Sec. 10.205,
representatives of the electronic media may be permitted, subject to
the procedures and limitations in Sec. 10.206, to videotape, film, or
otherwise record FDA's public administrative proceedings, including
presentations by participants. The hearings will be transcribed as
stipulated in Sec. 15.30(b). The transcript will be available on the
Internet at https://www.fda.gov/ohrms/dockets/default.htm, and orders
for copies of the transcript can be placed at the hearing or through
the Division of Dockets Management (see ADDRESSES).
Any handicapped persons requiring special accommodations to attend
the hearings should direct those needs to the contact person (see FOR
FURTHER INFORMATION CONTACT).
To the extent that the conditions for the hearings, as described in
this notice, conflict with any provisions set out in part 15, this
notice acts as a waiver of these provisions as specified in Sec. Sec.
10.19 and 15.30(h). In particular, Sec. 15.21(a) states that the
notice of hearing will provide persons an opportunity to file a written
notice of participation with the Division of Dockets Management within
a specified period of time. If the public interest requires, e.g., if a
hearing is to be conducted within a short period of time, the notice
may name a specific FDA employee and telephone number to whom an oral
notice of participation may be given. If the public interest requires,
the notice may also provide for submitting notices of participation at
the time of the hearing. In this document, the conditions for the
hearings specify that notices of participation be submitted
electronically to an agency Internet site, to a contact person (outside
of FDA) who will accept notices of participation
[[Page 8755]]
by mail, telephone, fax, or e-mail, or in person on the day of the
hearing (as space permits). We are using these procedures for
submitting notices of participation, rather than provide for the
submission of notices of participation to the Division of Dockets
Management, because the hearing is to be conducted within a short
period of time and these procedures are more efficient. In addition,
these procedures provide more flexibility to persons who wish to
participate in the hearings than would be provided if participants were
required to submit the notice of participation in writing to the
Division of Dockets Management. By delegation from the Commissioner
(Staff Manual Guide 1420.21, section 1(f)(2)(i)), the Associate
Commissioner for Policy and Planning finds under Sec. 10.19 that no
participant will be prejudiced, the ends of justice will thereby be
served, and the action is in accordance with law if notices of
participation are submitted by the procedures listed in this notice
rather than to the Division of Dockets Management.
V. How to Participate in the Hearings
Registration by submission of a notice of participation is
necessary to ensure participation and will be accepted on a first-come,
first-served basis. The notice of participation may be submitted
electronically (see ADDRESSES). The notice of participation also may be
submitted orally, by fax, or by e-mail (see ADDRESSES and FOR FURTHER
INFORMATION CONTACT). We encourage you to submit your notice of
participation electronically. A single copy of any notice of
participation is sufficient, except that any person who wishes to
participate in both hearings must submit a separate notice of
participation for each hearing.
The notice of participation must include your name, title, business
affiliation (if applicable), address, telephone number, fax number (if
available), and e-mail address (if available). If you wish to request
an opportunity to make an oral presentation during the open public
comment period of the hearing, your notice of participation also must
include the title of your presentation, the sponsor of the oral
presentation (e.g., the organization paying travel expenses or fees),
if any; and the approximate amount of time requested for the
presentation. Presentations will be limited to the questions and
subject matter identified in section III of this document, and,
depending on the number of requests received, we may be obliged to
limit the time allotted for each presentation.
Persons who wish to request an opportunity to make an oral
presentation at the March 20, 2007, public hearing must submit a notice
of participation (register) by March 2, 2007. All other persons wishing
to register to attend the March 20, 2007, public hearing must submit a
notice of participation by March 12, 2007. Persons who request an
opportunity to make an oral presentation at the March 20, 2007, public
hearing also must submit either the full text of the oral presentation,
or a comprehensive outline or summary of the oral presentation, by
March 12, 2007. Persons requiring special accommodations due to a
disability must register by March 6, 2007.
Persons who wish to request an opportunity to make an oral
presentation at the April 13, 2007, public hearing must submit a notice
of participation by March 23, 2007. All other persons wishing to
register to attend the April 13, 2007, public hearing must submit a
notice of participation by April 6, 2007. Persons who request an
opportunity to make an oral presentation at the second public hearing
also must submit either the full text of the oral presentation, or a
comprehensive outline or summary of the oral presentation, by April 6,
2007.
Under Sec. 15.20(c), if you request an opportunity to make an oral
presentation you must submit your presentation (either as the full text
of the presentation, or as a comprehensive outline or summary) by e-
mail or by fax. See ADDRESSES and FOR FURTHER INFORMATION CONTACT for
information on where to send your presentation.
Individuals who request an opportunity to make an oral presentation
will be notified of the scheduled time for their presentation prior to
the hearing. Depending on the number of oral presentations, we may need
to limit the time allotted for each oral presentation (e.g., 5 minutes
each). As stated earlier, we request that interested persons and groups
having similar interests consolidate their requests for oral
presentation and present them through a single representative. If you
need special accommodations due to a disability, please inform us (see
FOR FURTHER INFORMATION CONTACT).
We will also accept registration onsite; however, space is limited
and will be closed when the maximum seating capacity is reached. If
space is available, on-site registration will be accepted on a first-
come, first-served basis. Requests for an opportunity to make a
presentation from individuals or organizations that did not register to
make an oral presentation may be granted if time permits.
Persons who registered for the hearing should check in at the on-
site registration desk between 8:30 and 9 a.m. Persons who wish to
register onsite on the day of the hearing should do so at the
registration desk between 8:30 and 9 a.m. We encourage all participants
to attend the entire day. Because the hearings will be held in Federal
buildings, hearing participants must present photo identification and
plan adequate time to pass through the security system.
VI. Request for Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments in response to this
document and notice of hearings for consideration at or after the
hearings in addition to, or in place of, a request for an opportunity
to make an oral presentation (see section V of this document). Submit
two paper copies of any written comments, except that individuals may
submit one copy. Comments are to be identified with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday.
FDA is inviting public comment in writing and at the public
hearings. These comments are sought to inform FDA decisionmaking about
possible regulatory action with respect to the safety of fresh produce.
Written or electronic comments (i.e., submissions other than notices of
participation and the text, comprehensive outline, or summary of an
oral presentation) may be submitted until June 13, 2007. The
administrative record of the hearing will remain open until June 13,
2007.
VII. References
The following references have been placed on display in the
Division of Dockets Management (see ADDRESSES) and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday.
(FDA has verified the Web site addresses, but FDA is not responsible
for any subsequent changes to the Web sites after this document
publishes in the Federal Register.
1. Sivapalasingam, S., et al. ``Fresh Produce: A Growing Cause
of Outbreaks of Foodborne Illness in the United States, 1973 through
1997,'' Journal of Food Protection 67(10): 2342-53, 2004.
2. U.S. Food and Drug Administration, 1996-2006 Produce
Outbreaks (unpublished compilation).
3. U.S. Food and Drug Administration, FDA News Release, ``FDA
Warning on Serious Foodborne E. coli O157:H7
[[Page 8756]]
Outbreak,'' P06-131, September 14, 2006, available at https://
www.fda.gov/po/indexes/2006news.html.
4. U.S. Centers for Disease Control and Prevention, ``Update on
Multi-State Outbreak of E. coli O157:H7 Infections From Fresh
Spinach, October 6, 2006, available at https://www.cdc.gov/ecoli/
2006/september/updates/100606.htm.
5. U.S. Department of Health and Human Services and U.S.
Department of Agriculture, ``Dietary Guidelines for Americans
2005,'' January 2005, available at https://www.healthierus.gov/
dietaryguidelines/.
6. U.S. Food and Drug Administration, ``Guide to Minimize
Microbial Food Safety Hazards for Fresh Fruits and Vegetables,''
October 26, 1998, available at https://www.cfsan.fda.gov/~dms/
prodguid.html.
7. U.S. Food and Drug Administration, Center for Food Safety and
Applied Nutrition, Office of Plant and Dairy Foods, ``Letter to
Firms that Grow, Pack, or Ship Fresh Lettuce and Fresh Tomatoes,''
February 5, 2004, available at https://www.cfsan.fda.gov/~dms/
prodltr.html.
8. U.S. Food and Drug Administration, Center for Food Safety and
Applied Nutrition, Office of Plant and Dairy Foods, ``Letter to
California Firms that Grow, Pack, Process, or Ship Fresh and Fresh-
cut Lettuce,'' November 4, 2005, available at https://
www.cfsan.fda.gov/~dms/prodltr2.html.
9. U.S. Food and Drug Administration, ``Guide to Minimize
Microbial Food Safety Hazards of Fresh-Cut Fruits and Vegetables,''
March 2006, available at https://www.cfsan.fda.gov/~dms/
prodgui2.html.
10. U.S. Department of Health and Human Services, Public Health
Service, Food and Drug Administration, FDA Food Code, 2005,
available at https://www.cfsan.fda.gov/~dms/foodcode.html.
11. U.S. Food and Drug Administration, ``Produce Safety from
Production to Consumption: 2004 Action Plan to Minimize Foodborne
Illness Associated With Fresh Produce Consumption,'' October 2004,
available at https://www.cfsan.fda.gov/~dms/prodpla2.html.
12. Produce Marketing Association and United Fresh Fruit and
Vegetable Association, ``Commodity Specific Food Safety Guidelines
for the Melon Supply Chain,'' November 7, 2005, available at https://
www.cfsan.fda.gov/~dms/melonsup.html or https://www.cfsan.fda.gov/
~acrobat/melonsup.pdf.
13. International Fresh-Cut Produce Association, Produce
Marketing Association, United Fresh Fruit and Vegetable Association,
Western Growers Association; Commodity Specific Food Safety
Guidelines for the Lettuce and Leafy Greens Supply Chain; April 25,
2006, available at https://www.cfsan.fda.gov/~dms/lettsup.html or
https://www.cfsan.fda.gov/~acrobat/lettsup.pdf.
14. North American Tomato Trade Work Group, ``Commodity Specific
Food Safety Guidelines for the Fresh Tomato Supply Chain, May 2006,
available at https://www.cfsan.fda.gov/~dms/tomatsup.html or https://
www.cfsan.fda.gov/~acrobat/tomatsup.pdf.
Dated: February 21, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. 07-891 Filed 2-23-07; 8:45 am]
BILLING CODE 4160-01-S